|
Name |
Methyl 2-hydroxy-4-(3-hydroxy-5-methylphenoxy)-6-methylbenzoate
|
| Molecular Formula | C16H16O5 | |
| IUPAC Name* |
methyl 2-hydroxy-4-(3-hydroxy-5-methylphenoxy)-6-methylbenzoate
|
|
| SMILES |
CC1=CC(=CC(=C1)OC2=CC(=C(C(=C2)C)C(=O)OC)O)O
|
|
| InChI |
InChI=1S/C16H16O5/c1-9-4-11(17)7-12(5-9)21-13-6-10(2)15(14(18)8-13)16(19)20-3/h4-8,17-18H,1-3H3
|
|
| InChIKey |
YAIYRXPNTQJXBE-UHFFFAOYSA-N
|
|
| Synonyms |
4-Methoxycarbonyldiorcinol; CHEMBL2332158; methyl 2-hydroxy-4-(3-hydroxy-5-methylphenoxy)-6-methylbenzoate; 4-(3-Hydroxy-5-methylphenoxy)-2-methyl-6-hydroxybenzoic acid methyl ester
|
|
| CAS | NA | |
| PubChem CID | 71719401 | |
| ChEMBL ID | CHEMBL2332158 |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 288.29 | ALogp: | 3.9 |
| HBD: | 2 | HBA: | 5 |
| Rotatable Bonds: | 4 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 76.0 | Aromatic Rings: | 2 |
| Heavy Atoms: | 21 | QED Weighted: | 0.833 |
| Caco-2 Permeability: | -4.982 | MDCK Permeability: | 0.00001950 |
| Pgp-inhibitor: | 0.007 | Pgp-substrate: | 0.004 |
| Human Intestinal Absorption (HIA): | 0.009 | 20% Bioavailability (F20%): | 0.863 |
| 30% Bioavailability (F30%): | 0.185 |
| Blood-Brain-Barrier Penetration (BBB): | 0.082 | Plasma Protein Binding (PPB): | 99.16% |
| Volume Distribution (VD): | 0.583 | Fu: | 1.38% |
| CYP1A2-inhibitor: | 0.97 | CYP1A2-substrate: | 0.877 |
| CYP2C19-inhibitor: | 0.909 | CYP2C19-substrate: | 0.092 |
| CYP2C9-inhibitor: | 0.733 | CYP2C9-substrate: | 0.945 |
| CYP2D6-inhibitor: | 0.892 | CYP2D6-substrate: | 0.846 |
| CYP3A4-inhibitor: | 0.695 | CYP3A4-substrate: | 0.186 |
| Clearance (CL): | 12.434 | Half-life (T1/2): | 0.841 |
| hERG Blockers: | 0.056 | Human Hepatotoxicity (H-HT): | 0.061 |
| Drug-inuced Liver Injury (DILI): | 0.518 | AMES Toxicity: | 0.1 |
| Rat Oral Acute Toxicity: | 0.177 | Maximum Recommended Daily Dose: | 0.955 |
| Skin Sensitization: | 0.805 | Carcinogencity: | 0.612 |
| Eye Corrosion: | 0.019 | Eye Irritation: | 0.978 |
| Respiratory Toxicity: | 0.752 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC005402 | ![]() |
0.790 | D07MGA | ![]() |
0.283 | ||
| ENC000979 | ![]() |
0.677 | D0Y7PG | ![]() |
0.276 | ||
| ENC004713 | ![]() |
0.657 | D06GCK | ![]() |
0.273 | ||
| ENC002783 | ![]() |
0.653 | D0H2ZW | ![]() |
0.269 | ||
| ENC005290 | ![]() |
0.577 | D0S6JG | ![]() |
0.266 | ||
| ENC002445 | ![]() |
0.576 | D04AIT | ![]() |
0.264 | ||
| ENC003724 | ![]() |
0.569 | D03TPR | ![]() |
0.260 | ||
| ENC004643 | ![]() |
0.556 | D06RGG | ![]() |
0.260 | ||
| ENC000729 | ![]() |
0.542 | D0B0AX | ![]() |
0.245 | ||
| ENC003748 | ![]() |
0.527 | D0A1DH | ![]() |
0.245 | ||